The industrial gas detection series is modularly designed for easy integration and custom configurability.

Without proper CO2 monitoring, personnel in environments like restaurants, beverage distribution facilities, grow spaces, and laboratories are at significant risk. 

Yachting Pages https://yachting-pages.com/are proud to announce that they are now a Carbon Neutral business. A partnership with Yacht Carbon Offset has paid for the Carbon Credits to offset their own carbon footprint.

The eco-friendly business, 1Plus1 Challenge, is launching the O2 BAND Pro patch which contains innovative technology to enhance automotive fuel efficiency through global crowdfunding on Indiegogo.

Fuji released their new flagship camera this month, the X-Pro2. It is the first X-series camera to feature a 24MP sensor (compared to 16MP before) and it has a very interesting hybrid optical & electronic view finder. When I first […]

Saving the planet from climate change with a grain of sandToronto, ON – Every year, humans advance climate change and global warming – and quite likely our own eventual extinction – by injecting about 30 billion tonnes of carbon dioxide (CO₂) into the atmosphere. A team of scientists from the University of Toronto (U of T) […]

The proper design, installation, and maintenance of these valves is vital for the safe operation of R-744 refrigeration systems, especially in industrial and commercial applications.

Although CO₂ systems may seem a bit more complicated than HFC DX systems, they are actually quite similar, with the main difference being CO2’s higher pressure.

CO₂ refrigeration, which has gained significant traction in ice arenas and supermarket coolers, is now emerging as a groundbreaking technology revolutionizing the way we cool and heat across industries worldwide.

As the industry continues to evolve, it’s essential for HVACR contractors to embrace comprehensive training programs that address both foundational knowledge and hands-on experience with CO₂ systems.

Chillventa 2024, held Oct. 13-15 in Nuremberg, Germany, showcased some of the world’s most innovative technologies to more than 33,000 attendees from 49 countries. Through more than 250 presentations, visitors were privy to the latest developments driving innovation throughout the HVAC industry.

NASRC to offer free training event for refrigeration technicians in St. Louis who want to learn more about natural refrigerants, such as CO₂ and propane.

NASRC to offer free training event for refrigeration technicians in Pittsburgh who want to learn more about natural refrigerants, such as CO₂ and propane.

Ongoing and evolving U.S. Environmental Protection Agency (EPA) and Department of Energy (DOE) regulations have created a complex landscape for supermarket owners.

Target and Amazon have both recently announced plans to construct new stores that contain CO2 refrigeration systems, which will help the retailers significantly reduce carbon emissions and energy use.

These Emerson half-day CO₂ transcritical booster supermarket refrigeration courses will take place March 28, 29, and 30 at the Energy Education Center in Irwindale, California.

CO₂ refrigeration systems demand both classroom knowledge and hands-on experience, which is why blending theory with practice creates top-notch technicians.

Nothing surpasses ClO2 for deodorization and disinfection. ClO2 physically changes the chemical make up of germs and odor-causing compounds and then breaks down leaving no harmful residue.

The company cites a study where its Fillbee reusable packaging cut CO₂ emissions by nearly two-thirds compared to conventional beverage packaging.

The deal also extends the agreement to the new entity that may be formed by Vodafone's planned UK merger with Three, though that deal is under CMA investigation.

Read more: Vodafone UK and Virgin Media O2 enter new network-sharing deal

But amidst this concerning news, there are still rays of hope.

Berkeley chemists have created a reusable material that pulls carbon dioxide from the air and holds onto it until it can be stored.

Recycled water purity and fears of a fungal future.

Las emisiones mundiales de dióxido de carbono (CO2) debidas a la energía fósil, el principal factor de calentamiento de la Tierra, siguen sin tocar techo. via Pocket

We have a friend from Flipora, which we did not know we had... Oh sorry our mistake, iyaloo27@gmail.com is not our friend, he/she is a spammer and spammers are our enemy.

To combat climate change, scientists are working to remove carbon dioxide from the atmosphere.

Read the in depth Review of O2Cure Hulk Air Purifier. Know detailed info about O2Cure Hulk configuration, design and performance quality along with pros & cons, Digit rating, verdict based on user opinions/feedback.

The bulk of these emissions are from burning coal, oil and gas. Those emissions would total 37.4 billion tons in 2024, up by 0.8% in 2023, the report said.

Microbes that rapidly convert CO2 to rock could lock away the greenhouse gas in deep underground storage sites, such as depleted oil and gas reservoirs

An annual accounting of CO2 emissions from burning fossil fuels and land use change finds no sign emissions will peak this year

Disclosure: I sit on the Planning Committee for the FDLI Ad-Promo conference. This is an unpaid, volunteer position. The contents of this post were not discussed with or influenced by any member of the FDLI staff.

This post provides some of the highlights from FDLI's ad-promo conference. An on-demand version of the conference presentations is available on-demand at: https://www.fdli.org/2023/11/advertising-promotion-for-medical-products-conference-on-demand/

The Food and Drug Law Institute's (FDLI) Advertising & Promotion for Medical Products conference wrapped up last week. I attended the conference and also moderated a panel on data privacy and concerns about the use of health data for the targeting of advertising.

The first day kicked off with a fireside chat with Arun Rao from the Department of Justice (DOJ), Lauren Roth from the Food & Drug Administration (FDA), and Serena Viswanathan from the Federal Trade Commission (FTC), led by Christine Simmon of FDLI.

FDA and FTC both noted their recent guidance updates. For FDA, that means the new Communications From Firms to Health Care Providers Regarding Scientific Information on Unapproved Uses of Approved/Cleared Medical Products Questions and Answers Guidance for Industry (SIUU) and the newly finalized Presenting Quantitative Efficacy and Risk Information in Direct-to-Consumer (DTC) Promotional Labeling and Advertisements. 

FTC has also been busy, providing updated guidance on endorsements, reviews and testimonials, and a distinct Health Products Compliance Guidance.

DOJ, FDA, and FTC also mentioned the extent to which they are still very much digging out from the backlog created by the pandemic. More than three years after COVID-19 first came to our shores, its effects are very much still being felt.

Rao also mentioned a new policy from DOJ to create a safe harbor for self-reported disclosures made in connection with a merger or acquisition. Under this new policy, companies that learn of wrongdoing at a company they have acquired can be protected from later liability if they report the wrongdoing to DOJ within six months of closing the merger or acquisition. This is as Rao described it a "very big juicy carrot" to encourage self-reporting of wrongdoing, and it also ramps up the need for effective due diligence during the M&A to ensure that all wrongdoing is uncovered and can be reported.

One final point mentioned by Roth is the importance to FDA of combatting misinformation about medical products. Commissioner Califf has repeatedly warned about the need to combat misinformation, and it is not a stretch to see FDA's SIUU guidance as one small step in that direction. By providing further guidance about exactly how sponsors can share truthful, not misleading information about unapproved uses, FDA is enabling efforts to get good information from the people who should be seen as the most reliable source of that information, the product's sponsors.

The next session of the day included an update from OPDP, APLB, CDRH, and CVM related to advertising and promotion.

Katie Gray from OPDP gave a detailed presentation on the Recorlev enforcement action from earlier this year and an overview of the SIUU guidance. Lisa Stockbridge from APLB provided a reminder on reminder advertising, indicating that this well-established category of communication continues to cause firms difficulties. Debra Wolf of CDRH emphasized that although there has not been a significant amount of publicly available enforcement actions from CDRH, the Agency continues to have many private communications with firms about their marketing efforts.

The next plenary session covered scientific exchange and pre-approval communications. Elisabethann Wright of Cooley provided particular insight into the EU's approach, which of course varies widely by country, and has been especially active on platforms such as LinkedIn. Of note is the extremely active role played by the industry's own associations in not merely promulgating guidance and establishing codes of conduct but in regularly enforcing violations of those codes against member companies.

After lunch, the first set of breakout sessions occurred including the panel I moderated on data privacy. I found the discussion very lively and enjoyed hearing from Elisa Jillson from the FTC, Lyra Correa from HHS's Office of Civil Rights, and Nancy Perkins from Arnold & Porter. I have previously opined that the 2020s will be most known for its focus on privacy, and while the cookie-less future we keep hearing about gets pushed back once again, there's growing awareness and concern about how much deeply personal information has been given up and on how companies are using (or misusing) that data.

Simultaneous sessions looked at the recently finalized guidance from the FDA on Presenting Quantitative Efficacy and Risk Information in Direct-to-Consumer (DTC) Promotional Labeling and Advertisements while another session looked more into the promotion of veterinary products. Because I was leading another session, I couldn't attend either, but I'm looking forward to using that link provided earlier to view the recordings. 

The afternoon plenary sessions resumed with a look at FTC's role in enforcement of healthcare advertising and closed out with a session on that perennial chestnut of social media usage.

Day two of the conference kicked off with an enlightening discussion of so-called CFL (Consistent with FDA-Labeling) claims. Torrey Cope of Sidley Austin provided an insightful look not just at FDA's enforcement post-guidance for claims that failed to meet the CFL standard, but also for taking the time to examine the nature and wording around the acceptance by FDA of so-called Real-World Evidence (RWE) in the context of product approvals. RWE is not the sole source of CFL claims, but Cope was able to provide some valuable lessons.

The afternoon's breakout sessions included one on artificial intelligence (which I attended), promotional challenges in rare disease treatments, and navigating accelerated approval promotion.

The closing session focused on other avenues for enforcement, including of course, the Better Business Bureau National Advertising Division's (NAD), as well as general counsel to general counsel complaint letters, filing complaints with the FDA, and perhaps even bringing a Lanham Act case.

The NAD's finding against Novartis earlier this year was of course a hot topic. But it is worth noting that in a more recent case, Viiv simply declined to participate in the NAD process. NAD referred the matter to FDA and FTC noting that decision, but as of the writing of this post, no further action by the government has been seen.

Alan Minsk of Arnall Golden Gregory noted the importance of determining your goal when looking at the appropriate path. If your goal is get a competitor in trouble then you really need to rely on the government or the courts, but if your goal is primarily to just get the company to stop the use of misleading promotion, then NAD or a direct complaint letter might be a far more cost-effective solution.

Overall, the conference was a huge success, though my opinion should be viewed as biased because I sit on the conference planning committee. FDA is definitely digging itself out from the pandemic backlog. I fully expect we'll see more from the Agency, as a very active 2023 has already demonstrated.

BAKU — Global carbon dioxide emissions, including those from burning fossil fuels, are set to hit a record high this year, pulling the world further off course from averting more destructive climate extremes, scientists said on Wednesday (Nov 13). The Global Carbon Budget report, published during the UN's COP29 climate summit in Azerbaijan, said global CO2 emissions are set to total 41.6 billion metric tons in 2024, up from 40.6 billion tons last year. The bulk of these emissions are from burning coal, oil and gas. Those emissions would total 37.4 billion tons in 2024, up by 0.8 per cent in 2023, the report said. The rest are from land use, a category that includes deforestation and forest fires. The report by more than 80 institutions was led by the University of Exeter in UK. "We don't see a sign of fossil fuel emissions peaking in 2024," said lead author Pierre Friedlingstein, a climate scientist at the University of Exeter. Without immediate and steep emissions cuts worldwide, "we will just go straight into the 1.5C target, we'll just pass it and continue," he said.

An annual accounting of CO2 emissions from burning fossil fuels and land use change finds no sign emissions will peak this year

Government-owned power giant NTPC announced on Friday that in "a major groundbreaking achievement," it has been "successful in the synthesis of CO2 captured from flue gas with hydrogen produced from a PEM electrolyser, which was then converted into methanol at NTPC's Vindhyachal plant."